Yuichi Sakamori Selected Research

Yuichi Sakamori Research Topics

Disease

41	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2021 - 01/2010
18	Neoplasms (Cancer) 01/2021 - 07/2010
10	Lung Neoplasms (Lung Cancer) 01/2020 - 03/2010
9	Neoplasm Metastasis (Metastasis) 07/2022 - 03/2010
6	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 07/2022 - 05/2010
6	Adenocarcinoma of Lung 09/2017 - 02/2011
3	Disease Progression 05/2020 - 01/2013
3	Brain Neoplasms (Brain Tumor) 09/2013 - 04/2010
2	Interstitial Lung Diseases (Interstitial Lung Disease) 10/2017 - 08/2012
2	Pleural Effusion (Pleural Effusions) 09/2011 - 09/2010
2	Chronic Kidney Failure (Chronic Renal Failure) 04/2011 - 05/2010
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 01/2021
1	Carcinogenesis 09/2017
1	Hepatitis 08/2017
1	Neutropenia 05/2016
1	Thymoma (Thymic Carcinoma) 05/2016
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 09/2013
1	Pain (Aches) 03/2013
1	Dyspnea (Shortness of Breath) 03/2013
1	Lymphoma (Lymphomas) 01/2013
1	Lewis Lung Carcinoma 07/2012
1	Pneumonia (Pneumonitis) 07/2012
1	Malignant Mesothelioma 07/2012
1	Diarrhea 10/2011
1	Anorexia 10/2011
1	Hemorrhage 10/2011
1	Stomatitis 10/2011
1	Nausea 10/2011
1	Vomiting 10/2011
1	Malignant Pleural Effusion 09/2011
1	Pulmonary Embolism 08/2011
1	Infections 08/2011
1	Thrombosis (Thrombus) 08/2011
1	Venous Thrombosis (Deep-Vein Thrombosis) 08/2011

Drug/Important Bio-Agent (IBA)

14	ErbB Receptors (EGF Receptor)IBA 01/2017 - 01/2010
11	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2013 - 04/2010
8	Gefitinib (Iressa)FDA Link 09/2012 - 01/2010
6	Pemetrexed (MTA)FDA Link 05/2020 - 03/2011
6	Anaplastic Lymphoma KinaseIBA 01/2020 - 01/2013
5	Tyrosine Kinase InhibitorsIBA 01/2017 - 05/2010
4	NivolumabIBA 01/2021 - 01/2017
4	Bevacizumab (Avastin)FDA Link 05/2020 - 05/2011
4	alectinibIBA 01/2020 - 11/2018
4	CrizotinibIBA 01/2019 - 01/2013
3	Biomarkers (Surrogate Marker)IBA 01/2020 - 10/2011
3	SolventsIBA 10/2017 - 01/2015
3	Paclitaxel (Taxol)FDA LinkGeneric 10/2017 - 01/2015
3	Albumin-Bound Paclitaxel FDA Link 10/2017 - 05/2016
3	Epidermal Growth Factor (EGF)IBA 09/2012 - 04/2010
3	OSI-420IBA 09/2011 - 05/2010
2	Carboplatin (JM8)FDA LinkGeneric 05/2020 - 05/2016
2	amrubicinIBA 03/2020 - 05/2010
2	AlbuminsIBA 10/2017 - 07/2016
2	130-nm albumin-bound paclitaxelIBA 10/2017 - 07/2016
2	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 09/2017 - 09/2012
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2013 - 08/2011
2	Phosphotransferases (Kinase)IBA 01/2013 - 04/2010
2	Insulin-Like PeptidesIBA 09/2012 - 10/2011
2	Insulin-Like Growth Factor Binding Protein 3IBA 09/2012 - 10/2011
2	Pharmaceutical PreparationsIBA 08/2012 - 09/2011
1	Peptides (Polypeptides)IBA 07/2022
1	big gastrinIBA 07/2022
1	ATP-Binding Cassette Transporters (ABC Transporters)IBA 01/2020
1	Proteins (Proteins, Gene)FDA Link 01/2020
1	navitoclaxIBA 01/2020
1	Apoptosis Regulatory ProteinsIBA 01/2020
1	LigandsIBA 01/2020
1	S63845IBA 01/2020
1	saracatinibIBA 01/2019
1	src-Family KinasesIBA 01/2019
1	ceritinibIBA 11/2018
1	locked nucleic acidIBA 01/2017
1	Circulating Tumor DNAIBA 01/2017
1	Peptide Nucleic AcidsIBA 01/2017
1	Monoclonal AntibodiesIBA 09/2013
1	Docetaxel (Taxotere)FDA Link 06/2013
1	PlatinumIBA 06/2013
1	Vinorelbine (Navelbine)FDA LinkGeneric 06/2013
1	Morphine (MS Contin)FDA LinkGeneric 03/2013
1	ParaffinIBA 02/2013
1	Formaldehyde (Formol)FDA Link 02/2013
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2013
1	NOC 18IBA 07/2012
1	Antineoplastic Agents (Antineoplastics)IBA 07/2012
1	Nitroglycerin (Dynamite)FDA LinkGeneric 07/2012
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 07/2012
1	Folic Acid AntagonistsIBA 07/2012
1	Carrier Proteins (Binding Protein)IBA 10/2011

Therapy/Procedure

14	Drug Therapy (Chemotherapy) 12/2021 - 09/2010
12	Therapeutics 01/2021 - 01/2010
2	Aftercare (After-Treatment) 01/2020 - 09/2017
2	Renal Dialysis (Hemodialysis) 04/2011 - 05/2010
1	Cranial Irradiation 07/2022
1	Chemoradiotherapy 03/2020
1	Immunotherapy 01/2020
1	Drug Tapering 05/2016
1	Radiotherapy 09/2013
1	Oral Medicine 03/2013
1	Adjuvant Chemotherapy 01/2013
1	Retreatment 08/2012